Ledger.Open graph →

SEC Form D · filed July 21, 2015

AVAXIA BIOLOGICS, Inc

Offering

$5.0M

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

LEXINGTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

David S. Donabedian · Atlanta, GADirector Robert S. Manning · Lexington, MADirector Nada S. Jain · Lexington, MADirector John S. Edwards · Lexington, MADirector Henry S. Kay · Lexington, MADirector Barbara S. Fox · Lexington, MAExec · Director Christopher S. Kiritsy · Lexington, MADirector Peter J. Klein · San Clemente, CADirector Kathy P. Tune · San Clemente, CAExec · Director Earl R. Fender · San Clemente, CADirector Guy P. Nohra · San Clemente, CADirector Jeff R. Swiecki · San Clemente, CADirector Matthew Topley · King of Prussia, PADirector Convergence Management, LLC · King of Prussia, PADirector Convergence Fund GP, LLC · King of Prussia, PADirector Carl D. Roston · Miami, FLDirector Marc Cabrera · Miami, FLExec · Director 396 North Camino Mercado Property Manager LLC · Middleburg, VADirector John S. Edwards · Lexington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗